Hepatitis C Virus (HCV) Seroprevalence among Blood Donors in Ranchi,India

Autores/as

  • Manoj Kumar Dr. Manoj Kumar Tutor, Department of Microbiology Sri Krishna Medical College and Hospital, Muzaffarpur, Bihar – 842004 Telephone no. +91 9308533421 Email: [email protected]
  • Suresh Prasad Dr. Suresh Prasad, Professor, Department of Microbiology Rajendra Institute of Medical Sciences Ranchi – 834009 Telephone No - +91 9431174985 E mail: [email protected]
  • Anil Kumar Singh Dr. Anil Kumar Singh Associate Professor Department of Physiology Nalanda Medical College and Hospital Patna – 800020 Telephone. + 91 9835020703 Fax no. (91 0612) 2354871 E mail: [email protected]
  • Harsh Priya Dr. Harsh Priya, Assistant Professor, Department of Public Health Dentistry, Manipal College of Dental Sciences, Mangalore Manipal University. Mangalore 575001, Karnataka, India

Palabras clave:

HCV seroprevalence, HCV antibodies, blood donors, hepatitis C virus, signal HCV

Resumen

Injection drug use is generally considered to be predominant source of new HCV infection in developed countries, while unsafe therapeutic injection and transfusion are likely to be major modes of transmission in the developing world. The present study was conducted with the objective to detect the seroprevalence of HCV among blood donors at RIMS, Ranchi, and different blood banks in Ranchi, India. Convenience sample of 1834 blood donors participated in the study and were screened for the presence of HCV antibody in their sera. The tests carried out were Signal HCV and ELISA test (Span diagnostic, India). All donors were replacement donors. 1765 were male (96.24%). Out of 1834 donors, 3 (0.16%) donors were HCV positive, none being female. Prevalence of 0.22% was found in age group (21–30) years and 0.2% was found in age group (31–40) years.  It appeared from the present study that the overall prevalence of anti-HCV antibodies in blood donors of Ranchi is low, but this emphasizes the necessity for careful selection of blood donors and rigorous screening for HCV by all blood banks to provide safe blood and blood components.

Biografía del autor/a

  • Manoj Kumar, Dr. Manoj Kumar Tutor, Department of Microbiology Sri Krishna Medical College and Hospital, Muzaffarpur, Bihar – 842004 Telephone no. +91 9308533421 Email: [email protected]
    Dr. Manoj KumarTutor,Department of MicrobiologySri Krishna Medical College and Hospital,Muzaffarpur,Bihar – 842004Telephone no. +91 9308533421Email: [email protected]
  • Suresh Prasad, Dr. Suresh Prasad, Professor, Department of Microbiology Rajendra Institute of Medical Sciences Ranchi – 834009 Telephone No - +91 9431174985 E mail: [email protected]
    Dr. Suresh Prasad,Professor,Department of MicrobiologyRajendra Institute of Medical SciencesRanchi – 834009Telephone No - +91 9431174985E mail: [email protected]
  • Anil Kumar Singh, Dr. Anil Kumar Singh Associate Professor Department of Physiology Nalanda Medical College and Hospital Patna – 800020 Telephone. + 91 9835020703 Fax no. (91 0612) 2354871 E mail: [email protected]
    Dr. Anil Kumar SinghAssociate ProfessorDepartment of PhysiologyNalanda Medical College and HospitalPatna – 800020Telephone. + 91 9835020703Fax no. (91 0612) 2354871E mail: [email protected]
  • Harsh Priya, Dr. Harsh Priya, Assistant Professor, Department of Public Health Dentistry, Manipal College of Dental Sciences, Mangalore Manipal University. Mangalore 575001, Karnataka, India
    Dr. Harsh Priya,Assistant Professor,Department of Public Health Dentistry,Manipal College of Dental Sciences, MangaloreManipal University.Mangalore 575001,Karnataka,India.Telephone no. +91 988673887Fax no. (91 0824) 2422653 E mail: [email protected]

Descargas

Publicado

2012-05-23

Número

Vol. 2 Núm. 1 (2012)

Sección

Case Study

Licencia

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

·         I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.

·         I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).

·         I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.

·          I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

_______________

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.